← Leaderboards
Charles G. Mullighan
St. Jude Children'S Research Hospital
$25,123,215
Attributed
$28,722,142
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.8M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,221,218 · 16
By mechanism
U54$15,604,590 · 5
R35$10,372,840 · 1
P01$4,023,269 · 2
P50$3,680,783 · 1
R01$1,782,944 · 1
RC2$1,708,950 · 1
Top collaborators
- Cheryl L Willman4 shared
- Stephen Patrick Hunger3 shared
- Mignon Lee-Cheun Loh3 shared
- Michael J Borowitz2 shared
- Paul K Brindle2 shared
- Meenakshi Devidas2 shared
- Julie M Gastier-Foster2 shared
- Brent L Wood2 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Richard W Kriwacki$14,373,283
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaGenomicsHigh RiskAcute LeukemiaMolecularInsightBiologyMouse ModelMutationExperimental ModelsChildGenesEpigenetic ProcessTranslatingLeukemogenesisChromatinGeneticBaseChildhoodTargeted TreatmentGenetic TranscriptionFusion Oncogene ProteinsResponseSampling
Grant awards (60)
Fusion oncoprotein condensates in pediatric cancers$3,032,826
P01 · FY2025 · CA
Condensates in Leukemias$990,443
P01 · FY2025 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$902,351
R35 · FY2025 · CA · contact PI
Childhood Hematological Malignancies Training Program$289,454
T32 · FY2025 · CA · contact PI
Hematological Malignancies Program$64,171
P30 · FY2025 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$12,654
R35 · FY2025 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,037,401
R35 · FY2024 · CA · contact PI
Childhood Hematological Malignancies Training Program$244,925
T32 · FY2024 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$6,840
R35 · FY2024 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,092,000
R35 · FY2023 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,055,461
R35 · FY2023 · CA · contact PI
Childhood Hematological Malignancies Training Program$270,617
T32 · FY2023 · CA · contact PI
Experimental and preclinical modeling of NUP98-rearranged acute leukemia$161,500
U54 · FY2023 · CA · contact PI
Project 1$161,500
U54 · FY2023 · CA · contact PI
Hematological Malignancies Program$70,177
P30 · FY2023 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,055,461
R35 · FY2022 · CA · contact PI
Childhood Hematological Malignancies Training Program$289,502
T32 · FY2022 · CA · contact PI
Hematological Malignancies Program$70,177
P30 · FY2022 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,077,000
R35 · FY2021 · CA · contact PI
Genomic Profiling of T-cell Acute Lymphoblastic Leukemia in Children$381,969
R03 · FY2021 · CA
Childhood Hematological Malignancies Training Program$174,054
T32 · FY2021 · CA · contact PI
Hematological Malignancies Program$67,870
P30 · FY2021 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$940,706
R35 · FY2020 · CA · contact PI
Childhood Hematological Malignancies Training Program$212,395
T32 · FY2020 · CA · contact PI
Experimental and preclinical modeling of NUP98-rearranged acute leukemia$179,500
U54 · FY2020 · CA · contact PI
Experimental and preclinical modeling of NUP98-rearranged acute leukemia$159,625
U54 · FY2020 · CA · contact PI
Hematological Malignancies Program$70,177
P30 · FY2020 · CA · contact PI
Administrative Core$25,644
U54 · FY2020 · CA · contact PI
Project 1$25,643
U54 · FY2020 · CA · contact PI
Project 2$25,643
U54 · FY2020 · CA · contact PI
Genome Core$25,643
U54 · FY2020 · CA · contact PI
Genome Core$22,804
U54 · FY2020 · CA · contact PI
Administrative Core$22,804
U54 · FY2020 · CA · contact PI
Project 2$22,803
U54 · FY2020 · CA · contact PI
Project 1$22,802
U54 · FY2020 · CA · contact PI
Experimental and preclinical modeling of NUP98-rearranged acute leukemia$9,965,625
U54 · FY2019 · CA · contact PI
Project 1$2,015,880
U54 · FY2019 · CA · contact PI
Project 2$1,960,505
U54 · FY2019 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,044,690
R35 · FY2019 · CA · contact PI
CPML - Project 1: Genome-wide Studies of ALL Response$703,371
P50 · FY2019 · GM · contact PI
Genome Core$481,250
U54 · FY2019 · CA · contact PI
Administrative Core$325,419
U54 · FY2019 · CA · contact PI
Childhood Hematological Malignancies Training Program$201,210
T32 · FY2019 · CA · contact PI
Hematological Malignancies Program$67,924
P30 · FY2019 · CA · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,077,000
R35 · FY2018 · CA · contact PI
CPML - Project 1: Genome-wide Studies of ALL Response$731,794
P50 · FY2018 · GM · contact PI
Translating genomic discoveries to improved outcomes for high risk acute leukemia$1,071,276
R35 · FY2017 · CA · contact PI
CPML - Project 1: Genome-wide Studies of ALL Response$737,381
P50 · FY2017 · GM · contact PI
CPML - Project 1: Genome-wide Studies of ALL Response$737,381
P50 · FY2016 · GM · contact PI
Functional analysis of leukemic CREBBP mutations$363,125
R01 · FY2016 · CA · contact PI
CPML - Project 1: Genome-wide Studies of ALL Response$770,856
P50 · FY2015 · GM · contact PI
Functional analysis of leukemic CREBBP mutations$363,125
R01 · FY2015 · CA · contact PI
Functional analysis of leukemic CREBBP mutations$352,231
R01 · FY2014 · CA · contact PI
Functional analysis of leukemic CREBBP mutations$341,338
R01 · FY2013 · CA
Functional analysis of leukemic CREBBP mutations$363,125
R01 · FY2012 · CA
Identifying the spectrum of genetic alterations in high risk ALL$1,573,220
RC4 · FY2010 · CA · contact PI
Targeted Therapies for Childhood Acute Lymphoblastic Leukemia$876,194
RC2 · FY2010 · CA
GENOMIC ANALYSIS OF ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA$500,000
RC1 · FY2010 · CA · contact PI
Targeted Therapies for Childhood Acute Lymphoblastic Leukemia$832,756
RC2 · FY2009 · CA
GENOMIC ANALYSIS OF ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA$500,000
RC1 · FY2009 · CA · contact PI